Doxycycline (OncoSynergy) | m-entrepreneurship.com

Product Name :
Doxycycline (OncoSynergy)

Search keywords :
Doxycycline

drugId :
null

Target Vo:
30S ribosomal subunit

Target Vo Short Name :
30S subunit

Moa_Name:
30S ribosomal subunit inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Enochian Biosciences

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neurofibromatoses

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FEN1 Antibody (YA765)
OGT Antibody
Hsp90 beta Antibody: Hsp90 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Hsp90 beta. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts